I kliniske forsøg med over 4200 patienter blev TRAVATAN administreret 1 gang dagligt som monoterapi eller som supplerende terapi til timolol 0, 5%.
In clinical studies involving over 4200 patients, TRAVATAN was administered once daily as monotherapy or adjunctive therapy to timolol 0.5%.